The nation of Zimbabwe has turned down a major American healthcare agreement valued at $367m (272 million pounds) spanning five years because of Washington's request for sensitive data.
This rejection became public following a internal memorandum dated December was disclosed, revealing that President Emmerson Mnangagwa believed the arrangement was "unbalanced".
A government spokesperson has since stated that the US was demanding access to health data for research and commercial purposes while was unwilling to guarantee the benefits from future treatments.
"We are forced to start the difficult and regrettable process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for more negotiations to find a agreement agreeable to both sides so the country's critical HIV treatment initiative can continue.
Broader Implications
This development comes after a comparable case in Kenya, where a court halted a similar deal with the US after concerns were raised about the safety of citizens' medical information.
Since resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had overseen aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government deals to boost transparency and responsibility.
Based on statements, Sixteen nations in Africa have so far signed similar agreements, representing more than $18.3bn in new funding.
Specifics of the Declined Deal
The money for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"Zimbabwe was being asked to provide its biological resources and data for a long time, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," he stated.
"Effectively, our country would provide the raw materials for medical research with no assurance that the end products would be available to our population if a future health crisis arise."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining systems previously established through the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with future global health emergencies.
"This framework is designed to ensure that when a nation provides its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome further dialogue with our American counterparts on how future co-operation could be designed in a way that respects the independence and dignity of each country."
Medical Community Reaction
A leading public health body expressed it acknowledged the government's concerns, but suggested that negotiations must proceed considering a large portion of the nation's HIV programmes were funded by foreign aid.
"If technical issues arise, such as those relating to data governance or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group commented.
This impasse emphasises the ongoing challenges between accepting much-needed international aid and protecting a country's data in an increasingly interconnected world.